TMO DCF Analysis: Intrinsic Value $491 vs Price $622

gurufocus.com · 2026-08-31

On August 31, 2026, we conducted a DCF analysis for Thermo Fisher Scientific Inc (TMO), a company that has shown notable price performance over the past year. T

TickrTrends take: TMO is currently trading at $622 while a discounted cash flow analysis suggests an intrinsic value of $491, indicating the stock is priced above this DCF-derived estimate. This valuation gap aligns with TickrTrends' assessment that TMO is fairly valued, suggesting the market is pricing in expectations beyond the baseline cash flow projections. Investors focused on valuation metrics should monitor whether TMO's operational performance and growth trajectory can justify the premium at which it currently trades in the Healthcare sector.

Read the full story at gurufocus.com →